BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,099 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $207,517 | -0.1% | 5,368 | -2.5% | 0.02% | -11.8% |
| Q3 2023 | $207,794 | -9.6% | 5,506 | +9.2% | 0.02% | -10.5% |
| Q2 2023 | $229,780 | -49.1% | 5,043 | -54.7% | 0.02% | -55.8% |
| Q1 2023 | $451,765 | +89.0% | 11,138 | +262.0% | 0.04% | +87.0% |
| Q1 2022 | $239,000 | -14.3% | 3,077 | -5.4% | 0.02% | -11.5% |
| Q4 2021 | $279,000 | +6.1% | 3,251 | -0.6% | 0.03% | -7.1% |
| Q3 2021 | $263,000 | 0.0% | 3,271 | 0.0% | 0.03% | 0.0% |
| Q2 2021 | $263,000 | -20.8% | 3,271 | -16.9% | 0.03% | -26.3% |
| Q1 2021 | $332,000 | +1.5% | 3,934 | -3.6% | 0.04% | -7.3% |
| Q4 2020 | $327,000 | -1.2% | 4,079 | -1.0% | 0.04% | -8.9% |
| Q3 2020 | $331,000 | -12.9% | 4,121 | -6.8% | 0.04% | -19.6% |
| Q2 2020 | $380,000 | +15.5% | 4,420 | +9.1% | 0.06% | -15.2% |
| Q1 2020 | $329,000 | -11.3% | 4,050 | -8.8% | 0.07% | +1.5% |
| Q4 2019 | $371,000 | -4.1% | 4,443 | +0.2% | 0.06% | -14.5% |
| Q3 2019 | $387,000 | +5.4% | 4,435 | -1.1% | 0.08% | 0.0% |
| Q2 2019 | $367,000 | +1.9% | 4,486 | +1.1% | 0.08% | +2.7% |
| Q1 2019 | $360,000 | +26.8% | 4,439 | +2.9% | 0.07% | +7.2% |
| Q4 2018 | $284,000 | -24.5% | 4,315 | -10.6% | 0.07% | -1.4% |
| Q3 2018 | $376,000 | +12.9% | 4,828 | +6.9% | 0.07% | +4.5% |
| Q2 2018 | $333,000 | +30.6% | 4,516 | +12.1% | 0.07% | -11.8% |
| Q1 2018 | $255,000 | -8.9% | 4,027 | -0.9% | 0.08% | -5.0% |
| Q4 2017 | $280,000 | – | 4,064 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 53,850,000 | $2,054,378,000 | 20.84% |
| Smithwood Advisers, L.P. | 1,000,000 | $38,150,000 | 10.54% |
| SECTOR GAMMA AS | 937,600 | $35,769,000 | 9.19% |
| Smithwood Advisers, L.P. | 500,000 | $19,075,000 | 5.27% |
| Veritas Asset Management LLP | 10,592,749 | $404,113,000 | 5.07% |
| York Capital Management Global Advisors, LLC | 7,887,822 | $300,921,000 | 4.47% |
| Iguana Healthcare Management, LLC | 325,000 | $12,399,000 | 4.08% |
| Osher Van de Voorde Investment Management | 174,160 | $6,644,000 | 3.82% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $7,630,000 | 3.22% |
| Governors Lane LP | 600,000 | $22,890,000 | 3.22% |